MINERVA NEUROSCIENCES INC's ticker is NERV and the CUSIP is 603380106. A total of 37 filers reported holding MINERVA NEUROSCIENCES INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $16,000 | -46.7% | 20,000 | +17.6% | 0.00% | – |
| Q3 2021 | $30,000 | -65.1% | 17,000 | -54.1% | 0.00% | – |
| Q2 2021 | $86,000 | -15.7% | 37,000 | +5.7% | 0.00% | – |
| Q1 2021 | $102,000 | +24.4% | 35,000 | -0.5% | 0.00% | – |
| Q4 2020 | $82,000 | -26.8% | 35,175 | +0.2% | 0.00% | – |
| Q3 2020 | $112,000 | -11.8% | 35,100 | 0.0% | 0.00% | – |
| Q2 2020 | $127,000 | -15.9% | 35,100 | +40.4% | 0.00% | -100.0% |
| Q1 2020 | $151,000 | -29.1% | 25,000 | -16.7% | 0.00% | 0.0% |
| Q4 2019 | $213,000 | +9.8% | 30,000 | +20.0% | 0.00% | 0.0% |
| Q3 2019 | $194,000 | +14.8% | 25,000 | -16.7% | 0.00% | 0.0% |
| Q2 2019 | $169,000 | +7.6% | 30,000 | +50.0% | 0.00% | 0.0% |
| Q1 2019 | $157,000 | +16.3% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $135,000 | -28.2% | 20,000 | +33.3% | 0.00% | 0.0% |
| Q3 2018 | $188,000 | +113.6% | 15,000 | +7.1% | 0.00% | 0.0% |
| Q1 2018 | $88,000 | – | 14,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,800,000 | $28,588,000 | 4.05% |
| NEXTHERA CAPITAL LP | 107,000 | $1,092,000 | 0.95% |
| Monashee Investment Management LLC | 43,000 | $439,000 | 0.69% |
| DAFNA Capital Management LLC | 80,100 | $818,000 | 0.65% |
| Perceptive Advisors | 810,537 | $8,275,000 | 0.57% |
| Vivo Capital, LLC | 200,000 | $2,042,000 | 0.56% |
| Iguana Healthcare Management, LLC | 125,000 | $1,276,000 | 0.52% |
| HIGHLAND CAPITAL MANAGEMENT LP | 868,333 | $8,866,000 | 0.36% |
| EAM Investors, LLC | 197,025 | $2,012,000 | 0.30% |
| Virtus ETF Advisers LLC | 25,630 | $262,000 | 0.19% |